The effects of 5alpha-reduced androgens on maintenance and regeneration of prostate glands and seminal vesicles in castrated and hypophysectomized rats.
The effects of 5alpha-androstane-3alpha, 17beta-diol (3alpha-diol) and 5alpha-androstane-3beta, 17beta-diol (3beta-diol) were studied in rats hypophysectomized and treated daily for 30 days with the steroids, starting on the day of surgery (hypophysectomized, H) or 30 days following the removal of pituitary (hypophysectomized regressed, HR). The ability of 3beta-diol to maintain and restimulate the prostate glands and seminal vesicles of castrated (C) and castrated regressed (CR) rats, respectively, was also studied. This androgen (3beta-diol) was able to maintain as well as rejuvenate to some degree the sexual accessory glands of all treatment groups. The prostate glands and seminal vesicles in both castrated experimental groups showed increased stimulation with progressively higher dosages of 3beta-diol. At all dose levels, stimulation of seminal vesicles of CR rats was comparable to that of non-regressed castrates. The prostate glands, on the other hand, showed better maintenance in the higher dosage group. In H rats, the stimulation of sexual accessory glands by both androgens was not significantly different than normal controls. The seminal vesicles and prostate glands of HR rats treated with 3alpha-diol were well stimulated and comparable to those of H rats treated with 3alpha-diol. The seminal vesicles of HR rats treated with 3beta-diol were also well stimulated, though not to the extent as those with 3alpha-diol treatment. The prostate glands of the 3beta-diol treated HR rats were significantly smaller than those of the 3alpha-diol treatment group. However, these miniature glands were morphologically stimulated as evidenced by mitosis of parenchymal cells and accumulation of secretory products in the alveoli. This study clearly indicates that 3beta-diol is biologically active and the degree of stimulation varies with the animal preparation in which the androgens were tested.
D015113:Androstane-3,17-diol / Q000494:pharmacology*; D000731:Androstanes / Q000494:pharmacology*; D000818:Animals; D002369:Castration; D004305:Dose-Response Relationship, Drug; D007016:Hypophysectomy; D008297:Male; D009929:Organ Size / Q000187:drug effects; D010084:Oxidation-Reduction; D011467:Prostate / Q000187:drug effects* / Q000648:ultrastructure; D051381:Rats; D012038:Regeneration / Q000187:drug effects*; D012669:Seminal Vesicles / Q000187:drug effects* / Q000648:ultrastructure; D013091:Spermatogenesis / Q000187:drug effects
D000731:Androstanes; D015113:Androstane-3,17-diol